title: High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation.
authors.forename: C
authors.initials: C
authors.lastname: Shimazaki
authors.forename: R
authors.initials: R
authors.lastname: Uchida
authors.forename: S
authors.initials: S
authors.lastname: Nakano
authors.forename: K
authors.initials: K
authors.lastname: Namura
authors.forename: S-i
authors.initials: SI
authors.lastname: Fuchida
authors.forename: A
authors.initials: A
authors.lastname: Okano
authors.forename: M
authors.initials: M
authors.lastname: Okamoto
authors.forename: T
authors.initials: T
authors.lastname: Inaba
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D002454:Cell Differentiation / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D011719:Pyrazines / Q000008:administration & dosage*; D016103:Spinal Fractures / Q000150:complications*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D000469:Alkaline Phosphatase